The Medicines (Labelling and Advertising to the Public) Regulations 1978 No. 41

SCHEDULE 2

PART II

Column 1	Column 2	Column 3
System or part of the body	Purposes for which advertising is permitted	Restrictions on permitted advertisements
1. The gastro-intestinal system.	Relief of such symptoms as are commonly referred to as indigestion, heart-burn, hyperacidity, dyspepsia, halitosis (bad breath) or flatulence.	None.
	Symptomatic relief of colicky pain, stomach ache or nausea.	None.
	Relief of occasional or non-persistent diarrhoea or constipation.	None.
	Prevention of travel sickness or related symptoms.	None.
2. Liver, biliary system and pancreas.	None.
3. Kidneys and ureters.	None.
4. The nervous system.	Symptomatic relief of headache including migrainous headache.
	Prevention of migraine. Treatment of the condition known as neuralgia.	That advertisements consist solely of labelled containers or packages in which, or leaflets with which, a medicinal product is supplied.
5. The genito-urinary system and mammary glands.	Symptomatic relief of dysmenorrhea.	None.
	Relief of sore nipples during lactation by means of local applications.	None.
	Contraception by means of the use of spermicidal contraceptives.	The restrictions and requirements imposed by regulation 6 of these regulations.
6. The skin, hair and scalp.	Treatment, where applied to an external surface of the body, of acne.	None.
	Prevention or treatment of dandruff by means of external applications.	None.
	Temporary relief of psoriasis by application to an external surface of the body.
	Treatment, where applied to an external surface of the body, of eczema and skin allergies.
	Treatment of hard skin and corns by means of the application of corn plasters or solvents.	None.
	Prevention or treatment of contact dermatitis by means of protective applications.	None.
	Relief or prevention of common minor skin conditions including dry and chapped skin, cold sores, nettle rashes, pruritus, insect bites and napkin rash.	None.